Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aston Particle Technologies (APT) is a biotechnology company specializing in advanced drug delivery systems, specifically focusing on dry powder formulation. A spin-out from the Aston Pharmacy School at Aston University, the company has developed a proprietary platform technology called isothermal Surface Particle Stabilization (iSPS). This technology enables the dry powder coating of drug particles without the use of heat or solvents, making it ideal for heat-sensitive biologics and complex small molecules. APT's solutions are primarily targeted at respiratory, oral, and injectable delivery routes, offering pharmaceutical partners a way to optimize drug stability and performance.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aston Pharmacy.